Anxiety symptoms and preventive measures during the COVID-19 outbreak in Taiwan.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100968559 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-244X (Electronic) Linking ISSN: 1471244X NLM ISO Abbreviation: BMC Psychiatry Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, [2001-
    • Subject Terms:
      Health Behavior* ; Personal Protective Equipment* ; Quarantine*; Anxiety/*psychology ; Coronavirus Infections/*prevention & control ; Pandemics/*prevention & control ; Pneumonia, Viral/*prevention & control; Adult ; Aged ; Anxiety/epidemiology ; Betacoronavirus ; COVID-19 ; Coronavirus Infections/epidemiology ; Cross-Sectional Studies ; Disease Outbreaks ; Female ; Humans ; Logistic Models ; Male ; Middle Aged ; Pneumonia, Viral/epidemiology ; SARS-CoV-2 ; Severity of Illness Index ; Surveys and Questionnaires ; Taiwan/epidemiology ; Young Adult
    • Abstract:
      Background: It is hypothesized that anxiety and behavioral responses are intense at the beginning of an epidemic. The objective of this study was to investigate anxiety symptoms and use of preventive measures against COVID-19. The study also compared the association between preventive measures and anxiety symptoms during the week immediately preceding the study and those symptoms and measures at the beginning of the outbreak.
      Methods: A cross-sectional population survey using an online questionnaire commenced on 14 February 2020. The study participants were residents of Taiwan ages 20 to 70 years. The 6-item state version of the State-Trait Anxiety Inventory (STAI-6) was used to assess anxiety symptoms. The questions about preventive measures asked participants about their personal protection, cough etiquette, contact precautions, voluntary quarantine, and prompt reporting. Multivariable logistic regression was used to determine the factors influencing an increase in the preventive measures scores.
      Results: Of a total of 3555 completed responses, a total of 52.1% (95% confidence interval [CI] 50.4-53.7) of the respondents reported moderate to severe levels of anxiety symptoms in the past week, whereas 48.8% (95%CI 47.2-50.5) reported moderate to severe anxiety symptoms at the beginning of the outbreak. With a higher score indicating greater anxiety, the median scores for anxiety symptoms in the past week and at the beginning of the outbreak were 46.7 (IQR [interquartile range] 36.7-53.3) and 43.3 (IQR 36.7-53.3), respectively. The median scores for the preventive measures taken in the past week and at the beginning of the outbreak were 26.0 (IQR 21.0-30.0) and 24.0 (IQR 19.0-28.0), respectively, out of a maximum score of 36. In the multivariable analysis, an increased anxiety symptom score from the beginning of the outbreak to the past week (adjusted OR = 7.38, 95%CI 6.28-8.66) was a strongly significant determinant of an increased preventive measures score in the past week compared with the score at the beginning of the outbreak.
      Conclusions: Anxiety and preventive measures scores were high and increased with the epidemic rate. Higher anxiety was associated with an increased use of preventive measures against COVID-19.
    • References:
      Immunol Allergy Clin North Am. 2011 Feb;31(1):133-40. (PMID: 21094928)
      J Infect Dis. 2010 Sep 15;202(6):867-76. (PMID: 20677945)
      BMC Pregnancy Childbirth. 2019 Oct 28;19(1):385. (PMID: 31660889)
      BMC Public Health. 2008 Oct 03;8:347. (PMID: 18831770)
      PLoS One. 2016 Apr 05;11(4):e0153147. (PMID: 27045195)
      Br J Clin Psychol. 1983 Nov;22 (Pt 4):245-9. (PMID: 6640176)
      Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151. (PMID: 32064853)
      J Med Internet Res. 2020 May 19;22(5):e19556. (PMID: 32369026)
      BMJ Glob Health. 2018 Mar 17;3(2):e000471. (PMID: 29607096)
      J Affect Disord. 2015 Nov 1;186:74-82. (PMID: 26232750)
      Lancet. 2020 Mar 14;395(10227):912-920. (PMID: 32112714)
      J Psychiatr Res. 2011 Aug;45(8):1027-35. (PMID: 21439576)
      Psychol Bull. 2004 Jul;130(4):601-30. (PMID: 15250815)
      Lancet. 2020 Feb 22;395(10224):565-574. (PMID: 32007145)
      J Epidemiol Community Health. 2003 Nov;57(11):864-70. (PMID: 14600111)
      Lancet. 2020 Feb 22;395(10224):e37-e38. (PMID: 32043982)
      Infect Control Hosp Epidemiol. 2004 Dec;25(12):1033-41. (PMID: 15636289)
      JAMA. 2020 Mar 3;:. (PMID: 32125371)
      Br J Clin Psychol. 1992 Sep;31(3):301-6. (PMID: 1393159)
      Gen Psychiatr. 2020 Mar 6;33(2):e100213. (PMID: 32215365)
      Int J Environ Res Public Health. 2020 Mar 06;17(5):. (PMID: 32155789)
      J Genet Couns. 2017 Dec;26(6):1348-1356. (PMID: 28667567)
      Psychol Bull. 2006 Nov;132(6):959-92. (PMID: 17073529)
      Clin Infect Dis. 2005 Jun 15;40(12):1713-20. (PMID: 15909256)
      J Clin Psychol. 1993 May;49(3):349-58. (PMID: 8315037)
      J Nurs Meas. 2009;17(1):19-28. (PMID: 19902657)
      BMJ. 2009 Jul 02;339:b2651. (PMID: 19574308)
    • Grant Information:
      National Taiwan Normal University. International National Taiwan Normal University.
    • Contributed Indexing:
      Keywords: COVID-19; Preventive measures; Public anxiety; STAI-6; Taiwan
    • Publication Date:
      Date Created: 20200718 Date Completed: 20200730 Latest Revision: 20201218
    • Publication Date:
      20240105
    • Accession Number:
      PMC7364127
    • Accession Number:
      10.1186/s12888-020-02786-8
    • Accession Number:
      32677926